By comparing the gene expression profiles of orthotopic and subcutaneous PCa tumours, we selected five widely used CSC markers (ALDH, CD44, CXCR4, α2β1 and CD24) to sort candidate PCSCs from orthotopic PCa tumours. The gene discussed is CD44; the disease is posterior cortical atrophy.